Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Dyshidrotic eczema
ADR ID BADD_A01362
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.04      Dermatitis and eczema
23.03.04.034      Dyshidrotic eczema
Description A recurrent eczematous reaction characterized by the development of vesicular eruptions on the palms and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. (Dorland, 27th ed) [MeSH]
MedDRA Code 10013913
MeSH ID D011146; D011146; D011146
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cheiropompholyx | Dyshidrosis | Dyshidrotic eczema | Podopompholyx | Pompholyx | Pompholyx eczema | Dyshidrosis lamellosa sicca | Eczema, Dyshidrotic | Dyshidrotic Eczema | Dyshidrotic Eczemas | Eczemas, Dyshidrotic | Vesicular Palmoplantar Eczema | Eczema, Vesicular Palmoplantar | Eczemas, Vesicular Palmoplantar | Palmoplantar Eczema, Vesicular | Palmoplantar Eczemas, Vesicular | Vesicular Palmoplantar Eczemas | Eczema, Dyshydrotic | Dyshydrotic Eczema | Dyshydrotic Eczemas | Eczemas, Dyshydrotic
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000404%
BADD_D00156Apremilast0.001158%
BADD_D00326Butylscopolamine bromide--
BADD_D00356Carbamazepine0.000842%
BADD_D00898Finasteride0.000321%
BADD_D01119Ibrutinib0.000533%
BADD_D01638Oxiconazole--
BADD_D01639Oxiconazole nitrate--
The 1th Page    1    Total 1 Pages